Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Tuesday, December 31, 2024.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -1.75.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-258.25
EARNINGS PER SHARE (EPS) AVG 3Y
-228.81
EARNINGS PER SHARE (EPS) AVG 5Y
-176.13
EARNINGS PER SHARE (EPS) AVG 10Y
-132.94
EARNINGS PER SHARE (EPS) AVG 15Y
-93.26
EARNINGS PER SHARE (EPS) AVG 20Y
-95.62
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Scienture Holdings, Inc.
Market Cap
$5.88M
Earnings Per Share (EPS)
N/A
TTM Avg
-258.25
3Y Avg
-228.81
5Y Avg
-176.13
Market Cap
$5.89M
Earnings Per Share (EPS)
-2.92
TTM Avg
-6.51
3Y Avg
-19.53
5Y Avg
-13.36
Market Cap
$5.89M
Earnings Per Share (EPS)
537.52
TTM Avg
197.33
3Y Avg
123.75
5Y Avg
69.48
Market Cap
$5.79M
Earnings Per Share (EPS)
-1.22
TTM Avg
-2.34
3Y Avg
-6.29
5Y Avg
-11.33
Market Cap
$5.77M
Earnings Per Share (EPS)
-1.35
TTM Avg
-3.54
3Y Avg
-9.29
5Y Avg
-9.12
Market Cap
$5.67M
Earnings Per Share (EPS)
-520.08
TTM Avg
-794.41
3Y Avg
-1655.89
5Y Avg
-3031.26
Market Cap
$5.66M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.92
3Y Avg
-0.62
5Y Avg
-0.53
Market Cap
$5.63M
Earnings Per Share (EPS)
-3.55
TTM Avg
-11.46
3Y Avg
-17.07
5Y Avg
-17.09
Market Cap
$6.28M
Earnings Per Share (EPS)
-4.57
TTM Avg
-13.10
3Y Avg
-16.05
5Y Avg
-14.80
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | $5.88M | N/A | -258.25 | -228.81 | -176.13 |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $5.89M | -2.92 | -6.51 | -19.53 | -13.36 |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.89M | 537.52 | 197.33 | 123.75 | 69.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA)vs › | $5.79M | -1.22 | -2.34 | -6.29 | -11.33 |
| Lucyd, Inc (LUCY)vs › | $5.77M | -1.35 | -3.54 | -9.29 | -9.12 |
| enVVeno Medical Corporation (NVNO)vs › | $5.67M | -520.08 | -794.41 | -1655.89 | -3031.26 |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.66M | N/A | -0.92 | -0.62 | -0.53 |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | -3.55 | -11.46 | -17.07 | -17.09 |
| Femasys Inc. (FEMY)vs › | $6.28M | -4.57 | -13.10 | -16.05 | -14.80 |
| Soligenix, Inc. (SNGX)vs › | $5.31M | -1.27 | -3.56 | -24.18 | -53.12 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
$-0.23
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2024-12-31 | 67.25 |
| 2023-12-31 | -583.75 |
| 2022-12-31 | -153.75 |
| 2021-12-31 | -245.00 |
| 2020-12-31 | -123.50 |
| 2019-12-31 | -18.00 |
| 2018-12-31 | 0.63 |
| 2017-12-31 | 22.50 |
| 2016-12-31 | -196.75 |
| 2015-12-31 | -80.25 |
| 2014-12-31 | -151.75 |
| 2013-12-31 | -333.75 |
| 2012-12-31 | 0.00 |
| 2011-12-31 | 0.00 |
| 2008-12-31 | -615752.00 |
| 2007-12-31 | -599.75 |
| 2006-12-31 | -185.75 |
| 2005-12-31 | -36.25 |
